Form 4: IGM Biosciences CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Misbah Tahir, CFO of IGM Biosciences, sold 1,487 shares of common stock on September 13, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 13, 2024, Misbah Tahir, the Chief Financial Officer of IGM Biosciences, Inc., sold 1,487 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $11.5388, with individual trades ranging from $11.20 to $11.795.
- Following the transaction, Tahir directly owns 122,694 shares of IGM Biosciences common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing related to insider transactions. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The sale of shares by the CFO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock sale transaction. |
| 09/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.